[#item_full_content] Despite growing optimism among institutional investors, US cannabis stocks remain in limbo, awaiting federal rescheduling. The delay in reform keeps capital at bay, with the potential for major market shifts hinging on regulatory changes. Could 2027 be the turning point? 
Read More
Institutional Interest Grows, But Cannabis Capital Waits
ByPot Shop News
October 26, 2026